KalVista Pharmaceuticals ... (KALV)
7.85
0.45 (6.08%)
At close: Jan 15, 2025, 3:59 PM
7.86
0.13%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -126.64M | -92.91M | -82.34M | -46.24M | -29.12M | -20.82M | -15.80M | -18.60M | -11.44M | -7.23M | -5.68M | -2.05M |
| Depreciation & Amortization | 816.00K | 718.00K | 564.00K | 537.00K | 512.00K | 378.00K | 180.00K | 40.00K | 33.00K | 38.00K | 27.00K | 38.00K |
| Stock-Based Compensation | 21.91M | 9.92M | 11.09M | 7.12M | 4.45M | 2.97M | 1.06M | 394.00K | 118.00K | 36.00K | 238.00K | 47.00K |
| Other Working Capital | 2.67M | 6.31M | -14.01M | 8.20M | -19.64M | -20.32M | 25.56M | -2.58M | -584.00K | 617.00K | 145.00K | 43.00K |
| Other Non-Cash Items | -485.00K | 84.00K | 4.88M | 114.00K | 13.00K | -103.00K | -651.00K | -1.37M | -1.66M | 167.00 | 32.00K | 104.00K |
| Deferred Income Tax | n/a | -491.00K | n/a | -42.00K | -33.00K | n/a | n/a | n/a | n/a | n/a | 63.00K | -6.00K |
| Change in Working Capital | 15.17M | 7.41M | -12.32M | 8.35M | -20.64M | -18.79M | 25.77M | -4.18M | -210.00K | 784.00K | 460.00K | 35.00K |
| Operating Cash Flow | -89.23M | -75.26M | -78.13M | -30.17M | -44.82M | -36.37M | 10.56M | -23.72M | -13.16M | -6.37M | -4.86M | -1.83M |
| Capital Expenditures | -443.00K | -1.20M | -931.00K | -82.00K | -220.00K | -1.08M | -1.43M | -74.00K | -11.00K | -125.00K | -18.00K | -91.00K |
| Acquisitions | n/a | -57.86M | -57.86M | 147.65M | -16.75M | 69.42M | n/a | 34.14M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -189.23M | -98.25M | -136.92M | -201.21M | -49.80M | -79.89M | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 104.95M | 140.86M | 195.71M | 53.64M | 66.77M | 11.55M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -443.00K | 57.86M | 57.86M | -147.65M | 16.75M | -69.42M | -1.43M | 34.14M | -715.00K | n/a | n/a | n/a |
| Investing Cash Flow | -84.72M | 41.41M | 57.86M | -147.65M | 16.75M | -69.42M | -1.43M | 34.06M | -11.00K | -125.00K | -18.00K | -91.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | -54.00K | -209.00K | -151.00K | n/a | n/a | n/a | 388.00K | -389.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 53.77M | 1.53M | 1.58M | 1.53M | 216.00K | 242.00K | n/a | 2.00K | 66.00M | 17.32M | 6.01M | 5.95M |
| Financial Cash Flow | 150.71M | 58.12M | 1.58M | 212.12M | 11.58M | 87.94M | 8.99M | 2.00K | 33.00M | 8.66M | 6.42M | 5.56M |
| Net Cash Flow | -24.45M | 25.51M | -19.86M | 34.80M | -16.22M | -19.05M | 20.11M | 9.19M | 19.24M | 2.04M | 1.54M | 3.64M |
| Free Cash Flow | -89.67M | -76.46M | -79.06M | -30.25M | -45.04M | -37.45M | 9.13M | -23.80M | -13.17M | -6.49M | -4.88M | -1.93M |